Cargando…
MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering
The receptor tyrosine kinase MET and its ligand, the hepatocyte growth factor, are essential to embryonic development, whereas deregulation of MET signaling is associated with tumorigenesis leading to various cancers, including lung carcinoma. Mutations in the MET kinase domain lead to constitutive...
Autores principales: | Montagne, Rémi, Baranzelli, Anne, Muharram, Ghaffar, Catherine, Leroy, Lesaffre, Marie, Vinchent, Audrey, Kherrouche, Zoulika, Werkmeister, Elisabeth, Cortot, Alexis B, Tulasne, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355264/ https://www.ncbi.nlm.nih.gov/pubmed/28061464 http://dx.doi.org/10.18632/oncotarget.14499 |
Ejemplares similares
-
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity
por: Lefebvre, J, et al.
Publicado: (2013) -
Hypoxia leads to decreased autophosphorylation of the MET receptor but promotes its resistance to tyrosine kinase inhibitors
por: Mekki, Meriem Sarah, et al.
Publicado: (2018) -
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)‐dependent oncogenic driver in vitro and in humanised HGF knock‐in mice
por: Fernandes, Marie, et al.
Publicado: (2023) -
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
por: Baldacci, Simon, et al.
Publicado: (2017) -
Necrosis- and apoptosis-related Met cleavages have divergent functional consequences
por: Montagne, R, et al.
Publicado: (2015)